AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GEIGER COUNTER LIMITED

Fund Information / Factsheet Jan 24, 2024

7665_rns_2024-01-24_65a26e7c-387f-4c0f-9ba0-2d5c4997b6fa.html

Fund Information / Factsheet

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7747A

Geiger Counter Ltd

24 January 2024

NCIM - Geiger Counter Ltd - Fund Page

Geiger Counter Limited Plc 

Monthly Investor Report - December 

The full monthly factsheet is now available on the Company's website and a summary can be found below. 

NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd

Enquiries: 

For the Investment Manager 

CQS (UK) LLP 

Craig Cleland 

0207 201 5368 

For the Company Secretary and Administrator 

BNP Paribas S.A., Jersey Branch 

Dean Plowman/Ann-Marie Pereira 

01534 813 967/ 01534 709198 

----------------------------------------------------------------------- 

Fund Description 

The objective of the Geiger Counter Fund is to provide investors with the potential for capital growth through investment primarily in the securities of companies involved in the exploration, development and production of energy, predominantly within the uranium industry. Up to 30% of the value of the Company's investment portfolio may be invested in other resource-related companies from outside the energy sector.

Portfolio Managers 

Keith Watson and Robert Crayfourd 

Key Advantages for the Investor 

·      Access to mining assets in the uranium sector

·      May benefit from embedded subscription share

·      Low correlation to major asset classes

Key Fund Facts1 

Total Gross Assets £100.4m
Reference Currency GBP
Ordinary Shares:
Net Asset Value 67.07p
Mid-Market Price 54.00p
Net gearing 14.31%
Discount (19.49%)

Ordinary Share and NAV Performance2 

One Month Three Months One Year Three Years Five Years
(%) (%) (%) (%) (%)
NAV 1.21 2.44 44.02 169.03 270.35
Share Price 0.93 3.85 26.32 100.00 164.71

Commentary3 

The spot U3O8 price ended December at $91.50/lb, up 13.3% over the month.

Symbolic of its ever more influential role in electricity generation, nuclear power received

widespread endorsement from the COP 28 conference with an international agreement to triple installed generating capacity by 2050. This boosted uranium price momentum into the calendar

year-end.

The passing of a US House vote to restrict the importation of Russian-sourced material saw the bill progress through to the Senate for consideration, potentially adding impetus to fuel prices. However, equities did not keep pace with the uranium price rise with the Fund NAV gaining 1.2% in December, similar to the Solactive Uranium Pure Play Index sterling return.

During the month, Nexgen announced that it had received its provincial environmental permits, the first company in more than 20 years to receive full provincial EA approval for a uranium project in Saskatchewan. With all necessary First Nations benefits agreements already in place, we believe the development of the project has de-risked considerably. The issue of Federal permits, which includes an official assessment of the Environmental Impact Assessment by the Canadian Nuclear Safety Commission, and which is expected to be issued later this year, represents the final step required for the project's development. Permitting progress helped lift the Nexgen share price by over 5% in sterling terms over the month. Fission Energy, which owns the neighbouring Patterson Lake project, rose by nearly 9% in sterling terms over the month.

Physically backed vehicles such as the Sprott Uranium Trust and Yellow Cake also struggled to keep pace with the uranium price rise, although both registered sterling returns of over 10% during December. The Sprott Trust share price briefly exceeded its NAV allowing it to purchase a modest 256k lbs of U3O8 during the month. The main detractors to Fund performance were Cameco and Ur-Energy, whose share prices slipped over 6.7% and 5.0% respectively in sterling terms during December.

Gross Leverage

(%)
Commitment Leverage

(%)
Geiger Counter Ltd 115 115

CQS (UK) LLP

4th Floor, One Strand, London WC2N 5HR, United Kingdom

T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200

CQS (US), LLC

152 West 57th Street, 40th Floor, New York, NY 10019, US

T: +1 212 259 2900 | F: +1 212 259 2699

CQS (Hong Kong) Limited

3305 AIA Tower, 183 Electric Road, North Point, Hong Kong, China

T: +852 3920 8600 | F: +852 2521 3189

Tavistock Communications

18 St. Swithin's Lane, London EC4N 8AD

T: +44 20 7920 3150 | [email protected]

Sources: 1R&H Fund Services (Jersey) Limited, as at the last business day of the month indicated at the top of this report. 2R&H Fund Services Limited/DataStream, as at the last business day of the month indicated at the top of this report, total return performance net of fees and expenses based on bid prices. These include historic returns and past performance is not a reliable indicator of future results. The value of investments can go down as well as up. Please read the important legal notice at the end of this document. 3Market data sourced from Bloomberg unless otherwise stated. The Fund may since have exited some or all of the positions detailed in the commentary.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DOCEANFLASALEEA

Talk to a Data Expert

Have a question? We'll get back to you promptly.